Feb 27, 2020, 10:10 AM by Michael Croft

Feb 27, 2020, 04:15 AM by Michael Croft

ALBANY, NY, US - Feb 27, 2020 - Transparency Market Research delivers key insights on the global bio filter market. In terms of revenue, the global bio filter market is estimated to expand at a CAGR of ~7%, based on value, during the forecast period, owing to numerous factors, regarding which, TMR offers thorough insights and forecasts in the global bio filter market report

Feb 26, 2020, 14:00 PM by Michael Croft

Bio-IT World  The Pistoia Alliance yesterday released the latest Unified Data Model (UDM) file format, Version 6, supported by funding from Biovia, Elsevier, GSK, Novartis, and Roche (recently joined by BMS). V6 delivers a stable foundation for the collection and exchange of reaction data and empowers the community to move forward with its adoption. The release is built upon standard (Allotrope-compatible) vocabularies for units of measure and analytical methods, allowing the systems to be interoperable. As increased adoption of AI and ML in R&D continues, such industry-wide data standards are essential in the move toward the digitally driven Lab of the Future (LoTF).

Feb 26, 2020, 13:00 PM by Michael Croft

Bio-IT World  Cardiologist Eric Topol, author of the Creative Destruction of Medicine and The Patient Will See You Now has often written about medicine and technology. But Deep Medicine isn’t just about technology.

Feb 25, 2020, 17:16 PM by Michael Croft

SAN FRANCISCO BAY AREA, CA, US - Feb 25, 2020 - Paris, February 25, 2020 - Stilla Technologies, a leading provider of pioneering digital PCR (dPCR) solutions for high-precision genetic analyses, just announced it will be joining an initiative led by Yuzi Holdings and TusPark Science & Technology Service Group (TusPark) to donate two Naica Systems to City of Zhengzhou and City of Xinyang[1], in China, to help them better detect the coronavirus and monitor its mutations

Feb 25, 2020, 12:05 PM by Michael Croft

Feb 25, 2020, 10:09 AM by Michael Croft

HOPKINTON, MA, UNITED STATES - Feb 25, 2020 - Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for oncology and inflammatory diseases, today announced a new clinical collaboration with Roche (SIX:RO, ROG), to explore the co-administration of SB 11285, Spring Bank’s intravenously (IV)-administered STING (STimulator of INterferon Gene) agonist with Roche’s PD-L1 checkpoint inhibitor atezolizumab (Tecentriq®) in patients with advanced solid tumors

Feb 25, 2020, 09:15 AM by Michael Croft

BOSTON, MA, UNITED STATES - Feb 25, 2020 - The Pistoia Alliance, a global, not-for-profit alliance that works to lower barriers to innovation in life sciences R&D, today released the latest Unified Data Model (UDM) file format, Version 6, supported by funding from Biovia, Elsevier, GSK, Novartis, and Roche (recently joined by BMS)

Feb 25, 2020, 08:36 AM by Michael Croft

PRINCETON, NJ - Feb 25, 2020 - Certara®, the global model-informed drug development and decision support leader, today reported that it has acquired a range of modeling and simulation technology assets from In Silico Biosciences, Inc

Feb 25, 2020, 04:50 AM by Michael Croft

CAMBRIDGE AND LEEDS, UNITED KINGDOM - Feb 25, 2020 - Domainex Ltd., a fully integrated provider of drug discovery services from its Medicines Research Centre near Cambridge, UK, has entered into a research partnership with LUNAC Therapeutics Limited to discover novel anticoagulant therapies  that have a reduced risk of bleeding compared to current therapies

Feb 24, 2020, 10:20 AM by Michael Croft

LA VISTA, NE - Feb 24, 2020 - Streck R&D Scientific Manager Dr. Nicholas George will give a presentation on our newest blood collection tube, RNA Complete BCT, at the 27th International Molecular Medicine Tri-Conference in San Francisco

Feb 24, 2020, 09:32 AM by Michael Croft

CAMBRIDGE, MA - Feb 24, 2020 - TriNetX, the global health research network that revolutionizes clinical research and enables discoveries through the generation of real-world evidence (RWE), today announced that Raremark, a patient-data platform focused on rare disease, has partnered with the TriNetX network to bring more clinical trials to its community

Feb 24, 2020, 05:19 AM by Michael Croft

GLASGOW, SCOTLAND - Feb 24, 2020 - Altair Medical, a medical technology company developing a groundbreaking solution to the global opioid crisis, today announce that the US Food and Drug Administration (FDA) has awarded the Company Breakthrough Device designation for its RESPMETER(TM) wearable biosensor device

Feb 24, 2020, 05:13 AM by Michael Croft

DUBLIN, IRELAND - Feb 24, 2020 - Aalto Bio Reagents today announced the availability of its new recombinant SARS-CoV-2 nucleocapsid protein (code CK 6404) for diagnostic test manufacturers, vaccine developers and researchers globally

Feb 24, 2020, 03:31 AM by Michael Croft

SHIRLEY, NY - Feb 25, 2020 - As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics now launches a large range of antibodies against key immune molecules in zebrafish to enhance the research within the fish scientific community as well as mammalian immune disorders researches

Feb 21, 2020, 18:05 PM by Michael Croft

Bio-IT World MGI, part of global genomics leader BGI Group, announced the commercial availability of its sequencing instruments and reagent kits in the United States based on MGI’s own innovative CoolMPS sequencing chemistry, starting in April of this year.

Feb 20, 2020, 21:48 PM by Michael Croft

SHIRLEY, NY - Feb 21, 2020 - February 21, 2020, since its establishment in 2004, Creative Proteomics has served nearly 2 million researchers from different areas, including clinical, academia and industry

Feb 20, 2020, 10:30 AM by Michael Croft

Bio-IT World Contributed Commentary | Radiology is increasingly the key to synthesizing real world evidence with sufficient quality to shape drug performance. As a diagnostic toolset, imaging is one of the oldest and most widely used and clearly interpreted methods for measurement of outcomes. It is regularly used to measure disease progression and to determine the effectiveness of medical interventions. Imaging is also a common mechanism for early identification of disease that can be automated or extended through artificial intelligence (AI).

Feb 20, 2020, 09:40 AM by Michael Croft

REDCAR, UK - Feb 20, 2020 - Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, today announced a partnership with the Technical University of Denmark to develop engineered recombinant antibodies specific for animal toxins, such as toxins from snake venoms

Feb 19, 2020, 15:20 PM by Michael Croft

Bio-IT World | Some big investments are driving CRISPR-based therapeutics, cell therapies, sepsis diagnostics and more this year. Unspecified investments by pharma are further propelling Seqster’s health data management platform.